Conception · 3 hours ago
Scientist, In Vitro Gametogenesis (Reproductive Biology)
Conception is pioneering the future of reproductive biology by generating functional human eggs from induced pluripotent stem cells (iPSCs). They are seeking an exceptionally talented Scientist to develop and optimize methods for in vitro gametogenesis, focusing on hands-on experimentation and data analysis.
BiotechnologyHealth CareMedical
Responsibilities
Develop and optimize methods to generate mouse iPSC lines
Maintain, differentiate, and engineer mouse ESC and iPSC lines using CRISPR-based tools
Improve and standardize differentiation protocols to derive different gonadal cell types from mouse iPSCs and/or ESCs
Drive experimental design, troubleshooting, and protocol development for in-vitro gametogenesis studies
Analyze data and communicate findings internally, contribute to overall experimental design and process standardization within the team
Maintain rigorous documentation, data tracking, and communication of experimental progress
Qualification
Required
Experience level: PhD or equivalent work experience
Proven expertise in pluripotent stem cell culture and differentiation, with demonstrated skill in maintaining stable, high-quality cultures (mouse preferred; human acceptable)
Strong foundation in developmental biology and stem cell biology, ideally in mouse systems
Experience with interpreting and discussing sequencing datasets (e.g., 10x scRNAseq, Smart-seq2)
Strong scientific foundation and a track record of executing complex experiments with rigor
Mission-driven mindset and enthusiasm for high-impact work
Excellent communication, organization, and collaboration skills
Meticulous attention to detail and record-keeping
Preferred
Experience with one or more of the following is highly desirable: Immunofluorescence analysis, FACS sorting
Understanding of epigenetic regulation and developmental transitions is a plus
Benefits
Competitive pay
Company equity
Excellent healthcare benefits
Company
Conception
Conception is a company developing the technology to turn skin cells into viable human eggs.
Funding
Current Stage
Early StageTotal Funding
$20M2021-11-23Series Unknown· $20M
2020-08-03Seed
2019-05-03Convertible Note
Recent News
MIT Technology Review
2025-11-03
Company data provided by crunchbase